Protective effect of diphenylmethyl selenocyanate against CCl4-induced hepatic injury
β Scribed by Rajat Kumar Das; Sk. Ugir Hossain; Sudin Bhattacharya
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 384 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0260-437X
- DOI
- 10.1002/jat.1230
No coin nor oath required. For personal study only.
β¦ Synopsis
Organoselenocyanates represent an important class of chemopreventive agent, which possess antioxidative, antimutagenic as well as cancer chemopreventive properties. The present study is an attempt to evaluate the protective effect of diphenylmethyl selenocyanate -a synthetic organoselenocyanate against carbon tetrachloride (CCl 4 )-induced hepatic damage in Swiss albino mice in vivo.
Mice were pretreated with the Se-compound orally in a duration dependent manner (7 and 15 days) to observe its protective action against an acute toxic dose (24 h) of CCl 4 (single injection at a dose of 20 ΞΌ ΞΌ ΞΌ ΞΌ ΞΌl and 50 ΞΌ ΞΌ ΞΌ ΞΌ ΞΌl kg -1 b.w.) that induced hepatic necrosis and caused DNA damage (strand breaks) in the hepatocytes.
This study revealed that pretreatment with the Se-compound reduced the extent of massive hepatic necrosis in a duration dependent manner, but it had no modulatory effect on hepatocellular apoptosis caused by acute toxic doses of CCl 4 . It was also found that the Se-compound could significantly (P < < < < < 0.01) prevent the CCl 4 -induced elevation of DNA damage in hepatocytes measured by comet assay in a duration dependent manner.
So these findings will further strengthen the view that organoselenocyanate is an effective chemopreventive agent against acute hepatic damage, caused by halogenated alkanes such as CCl 4 .
π SIMILAR VOLUMES
## Background: Oxidative stress, often in association with decreased antioxidant defenses, plays a pathogenetic role in both initiation and progression of liver injuries, leading to almost all clinical and experimental conditions of chronic liver diseases. human paraoxonase 1 (hpon1) is a liver-syn
The aim of this work was to study if colchicine protects against CCI4 -induced changes in hepatic biochemical parameters by reducing cytochrome P-450, by comparing the effects of colchicine and SKF 525-A, a wellknown inhibitor of cytochrome P-450. Our results show that both drugs reduced the cytochr
The in vivo canalicular excretion clearance of tributylmethyl ammonium (TBuMA), a P-glycoprotein (P-gp) substrate, was previously reported to be unaffected by the induction of an experimental hepatic injury (EHI) by CCl 4 despite the increased expression of P-gp in the EHI liver. The objective of th